NAD+
Also known as: Nicotinamide Adenine Dinucleotide
Molecular Identifiers
Overview
Essential coenzyme for cellular energy metabolism. Declines with age. Supplementation aims to restore cellular levels to support DNA repair and mitochondrial function.
The main clinical interest around NAD+ is to restore cellular levels that decline with age, sustaining the activity of sirtuins (SIRT1-7), PARP (DNA repair), the mitochondrial electron transport chain, and circadian clock regulation. Sought effects include energy, recovery, cognitive support, and longevity context. Clinical evidence of functional impact in humans remains limited and mixed.
Technically not a peptide but a dinucleotide coenzyme, often categorized alongside peptides in the longevity market. There is no FDA/EMA/ANVISA regulatory approval for injectable NAD+ as therapy; it is widely administered in wellness clinics via intravenous or subcutaneous infusion as off-label use, with protocols of 50-250 mg, 2-3 times per week. It can cause flushing, nausea, and chest discomfort with rapid infusions — starting with a low dose is standard practice.
Small molecule — dinucleotide coenzyme (nicotinamide adenine dinucleotide), not a peptide
Half-life
~30 minutes (IV)
Administration Route
Intravenous or subcutaneous
Category
Specialized Research
Mechanism of Action
- Essential cofactor for sirtuins (SIRT1-7)
- Substrate for PARP (DNA repair)
- Support for the mitochondrial electron transport chain
- Circadian clock regulation
Dosage Protocol
Data compiled from the literature. This does not constitute medical advice.
| Parameter | Value |
|---|---|
| Dose | 50-250 mg per injection |
| Frequency | 2-3 times per week |
| Timing | Preferably morning |
| Duration | Continuous as tolerated |
Reported Side Effects
Adverse effects described in the literature. Severity and frequency vary between individuals.
- Flushing
- Nausea
- Cramps
- Chest discomfort (rapid infusion)
- Headache
Product Properties
| Purity | >98% |
| Appearance | White crystalline powder |
| Solubility | Freely soluble in water |
| Source | Chemical synthesis or enzymatic production |
| Storage | Store at -20°C desiccated for up to 2 years. At 2-8°C desiccated for up to 6 months. Reconstituted: use immediately or store at -20°C. Hygroscopic — protect from moisture. |
Presentations & Preparation
Vials of NAD+ found in the research market:
Reconstitution
- Diluent: Bacteriostatic water
- Volume: According to concentration
- Inject the diluent slowly
- Gently swirl until fully dissolved
- May cause flushing — start with a low dose
Storage
- Lyophilized: -20°C or refrigerated 2-8°C
- Reconstituted: Refrigerated 2-8°C (up to 14 days)
- Limited stability after reconstitution
- Protect from direct light
Scientific Studies
Published studies on NAD+.
Related Peptides
Aviptadil
50-150 mcg per administration (IV or subcutaneous) · 1-3 times daily per protocol
B7-33
Bronchogen
1-2 capsules orally (0.2 g per capsule, containing AKS-B peptide complex) · 1-2 times daily, with meals
Cardiogen
Chonluten
1-2 capsules orally (0.2 g per capsule, containing bronchial tissue peptide complex) · 1-2 times daily, with meals
Crystagen
1-2 capsules orally (0.2 g per capsule, containing AKS-6 peptide complex) · 1-2 times daily, before meals